Importantly, genetic and biochemical evidence have demonstrated that mutations in human PSEN1 and PSEN2 play a role in the development of familiar Alzheimer's disease by altering APP processing to increase the ratio between the more aggregation-prone Aβ42 peptide and the Aβ40 variant [13]. The gene discussed is PSEN2; the disease is Alzheimer disease.